EXODIAB: Excellence of Diabetes Research in Sweden
2221 – 2230 of 4166
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Albiglutide for the treatment of type 2 diabetes mellitus : An integrated safety analysis of the HARMONY phase 3 trials
(
- Contribution to journal › Article
-
Mark
Prediction of treatment response in patients with newly diagnosed type 2 diabetes : The Skaraborg diabetes register
(
- Contribution to journal › Article
-
Mark
Elevated miR-130a/miR130b/miR-152 expression reduces intracellular ATP levels in the pancreatic beta cell
(
- Contribution to journal › Article
-
Mark
GFAT1 phosphorylation by AMPK promotes VEGF-induced angiogenesis
(
- Contribution to journal › Article
-
Mark
Bioenergetic Impairment in Congenital Muscular Dystrophy Type 1A and Leigh Syndrome Muscle Cells
(
- Contribution to journal › Article
-
Mark
Coffee, tea and melanoma risk : findings from the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
-
Mark
Rosiglitazone drives cavin-2/SDPR expression in adipocytes in a CEBPα-dependent manner
(
- Contribution to journal › Article
-
Mark
An 'alpha-beta' of pancreatic islet microribonucleotides
(
- Contribution to journal › Article
-
Mark
Human Pancreatic β Cell lncRNAs Control Cell-Specific Regulatory Networks
(
- Contribution to journal › Article
-
Mark
Temporal trend of autonomic nerve function and HSP27, MIF and PAI-1 in type 1 diabetes
(
- Contribution to journal › Article